The New England journal of medicine, 2024-04, Vol.390 (15), p.1394-1407
- Kosiborod, Mikhail N.
- Petrie, Mark C.
- Borlaug, Barry A.
- Butler, Javed
- Davies, Melanie J.
- Hovingh, G. Kees
- Kitzman, Dalane W.
- Møller, Daniél V.
- Treppendahl, Marianne B.
- Verma, Subodh
- Jensen, Thomas J.
- Liisberg, Karoline
- Lindegaard, Marie L.
- Abhayaratna, Walter
- Ahmed, Fozia Z.
- Ben-Gal, Tuvia
- Chopra, Vijay
- Ezekowitz, Justin A.
- Fu, Michael
- Ito, Hiroshi
- Lelonek, Małgorzata
- Melenovský, Vojtěch
- Merkely, Bela
- Núñez, Julio
- Perna, Eduardo
- Schou, Morten
- Senni, Michele
- Sharma, Kavita
- van der Meer, Peter
- Von Lewinski, Dirk
- Wolf, Dennis
- Shah, Sanjiv J.
2024
Volltextzugriff (PDF)
Details
- Autor(en) / Beteiligte
- Kosiborod, Mikhail N.
- Petrie, Mark C.
- Borlaug, Barry A.
- Butler, Javed
- Davies, Melanie J.
- Hovingh, G. Kees
- Kitzman, Dalane W.
- Møller, Daniél V.
- Treppendahl, Marianne B.
- Verma, Subodh
- Jensen, Thomas J.
- Liisberg, Karoline
- Lindegaard, Marie L.
- Abhayaratna, Walter
- Ahmed, Fozia Z.
- Ben-Gal, Tuvia
- Chopra, Vijay
- Ezekowitz, Justin A.
- Fu, Michael
- Ito, Hiroshi
- Lelonek, Małgorzata
- Melenovský, Vojtěch
- Merkely, Bela
- Núñez, Julio
- Perna, Eduardo
- Schou, Morten
- Senni, Michele
- Sharma, Kavita
- van der Meer, Peter
- Von Lewinski, Dirk
- Wolf, Dennis
- Shah, Sanjiv J.
- Titel
- Semaglutide in Patients with Obesity-Related Heart Failure and Type 2 Diabetes
- Ist Teil von
- The New England journal of medicine, 2024-04, Vol.390 (15), p.1394-1407
- Ort / Verlag
- United States: Massachusetts Medical Society
- Erscheinungsjahr
- 2024
- Quelle
- MEDLINE
- Beschreibungen/Notizen
- Among patients with obesity-related heart failure with preserved ejection fraction and type 2 diabetes, semaglutide produced greater reductions in symptoms, physical limitations, and body weight than placebo at 1 year.
- Sprache
- Englisch
- Identifikatoren
- ISSN: 0028-4793, 1533-4406eISSN: 1533-4406DOI: 10.1056/NEJMoa2313917Titel-ID: cdi_proquest_miscellaneous_3034777787
- Format
- –
- Schlagworte
- Analysis of covariance, Antidiabetics, Body weight loss, C-reactive protein, Cardiology, Cardiology General, Cardiomyopathy, Congestive heart failure, Diabetes, Diabetes mellitus (non-insulin dependent), Diabetes Mellitus, Type 2 - drug therapy, Diabetic retinopathy, Double-Blind Method, Ejection fraction, Endocrinology, Gastrointestinal surgery, Glucagon-Like Peptides, Glucose, Heart Diseases, Heart Failure, Heart Failure - drug therapy, Humans, Intravenous therapy, Missing data, Obesity, Patients, Peptides, Placebos, Statistical analysis, Stroke Volume, Weight control